Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Evangelos Bouros
Observed names:
E. Bouros,
E., Bouros,
Evangelo Bouros
Institution:
Athens Medical Center
Observed institutions:
Democritus University of Thrace,
National and Kapodistrian University of Athens,
Athens Medical Center,
University Hospital of Alexandroupolis,
Sotiria General Hospital
ORCID:
0000-0002-4947-902X
Observed ORCID:
0000-0002-4947-902X
OpenAlex ID:
A5103242640
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
2013
·
Argyris Tzouvelekis
, Vassilis Paspaliaris
, et al.
·
Journal of Translational Medicine
·
260
PDF
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
2019
·
Argyris Tzouvelekis
, Georgia Gomatou
, et al.
·
CHEST Journal
·
191
Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis
2019
·
Vasilios Tzilas
, Evangelos Bouros
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
93
Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
2011
·
Argyris Tzouvelekis
, George Koliakos
, et al.
·
Journal of Translational Medicine
·
81
PDF
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
2021
·
Ole Hilberg
, Anna-Maria Hoffmann-Vold
, et al.
·
ERJ Open Research
·
80
PDF
Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
2012
·
Argyris Tzouvelekis
, Nikolaos Galanopoulos
, et al.
·
Pulmonary Medicine
·
69
PDF
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
2020
·
Katerina Antoniou
, Katerina Markopoulou
, et al.
·
ERJ Open Research
·
66
PDF
The Autotaxin—Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis
2018
·
Christiana Magkrioti
, Nikos Oikonomou
, et al.
·
Cancer Research
·
65
Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece
2018
·
Argyrios Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
62
Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
2020
·
Argyris Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Frontiers in Medicine
·
58
PDF
Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose‐derived stromal cells‐stromal vascular fraction in idiopathic pulmonary fibrosis
2018
·
Paschalis Ntolios
, Eleni Manoloudi
, et al.
·
The Clinical Respiratory Journal
·
57
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece
2019
·
Argyris Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
53
Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the ‘bed’ that counts and not ‘the sleepers’
2017
·
Ioannis P. Tomos
, Argyrios Tzouvelekis
, et al.
·
Expert Review of Respiratory Medicine
·
53
Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study
2017
·
Argyrios Tzouvelekis
, Paschalis Ntolios
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
48
Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
2017
·
Argyrios Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Frontiers in Medicine
·
47
PDF
Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern
2019
·
Vasilios Tzilas
, Argyrios Tzouvelekis
, et al.
·
European Respiratory Journal
·
44
PDF
Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
2020
·
Vasilios Tzilas
, Argyris Tzouvelekis
, et al.
·
ERJ Open Research
·
35
PDF
Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations
2016
·
Amit Kishore
, Veronika Žižková
, et al.
·
Frontiers in Immunology
·
26
PDF
Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts
2017
·
Evangelos Bouros
, Eirini Filidou
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
23
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
2021
·
Paschalis Ntolios
, Vassilios Tzilas
, et al.
·
Biomedicines
·
21
PDF
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation
2020
·
Spyros A. Papiris
, Demosthenes Bouros
, et al.
·
European Respiratory Journal
·
19
PDF
Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date
2020
·
Paschalis Ntolios
, Paschalis Steiropoulos
, et al.
·
BioDrugs
·
19
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
2011
·
Argyris Tzouvelekis
, Evangelos Bouros
, et al.
·
Pulmonary Medicine
·
18
PDF
Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study
2022
·
Effrosyni D. Manali
, Caroline Kannengiesser
, et al.
·
Respiration
·
17
Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population
2020
·
Katerina Sikorova
, Amit Kishore
, et al.
·
Expert Review of Respiratory Medicine
·
15
Show more works
View as search
Works count:
88
Citation count:
1,628
H-index:
20
I10-index:
27
Year
Topic
Type
